Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore

Background To compare RCB (Residual Cancer Burden) and Neo-Bioscore in terms of prognostic performance and see if adding pathological variables improve these scores. Methods We analysed 750 female patients with invasive breast cancer (BC) treated with neoadjuvant chemotherapy (NAC) at Institut Curie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2021-04, Vol.124 (8), p.1421-1427
Hauptverfasser:	Laas, Enora, Labrosse, Julie, Hamy, Anne-Sophie, Benchimol, Gabriel, de Croze, Diane, Feron, Jean-Guillaume, Coussy, Florence, Balezeau, Thomas, Guerin, Julien, Lae, Marick, Pierga, Jean-Yves, Reyal, Fabien
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1347 692/4028/67/1347 692/699/67/1059/99 Antineoplastic Agents - therapeutic use Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Cancer Research Chemotherapy Drug Resistance Epidemiology Female Humans Invasiveness Medical prognosis Middle Aged Molecular Medicine Neoadjuvant Therapy - methods Neoplasm Staging Neoplasm, Residual Oncology Population Prognosis Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!